Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 26 entries
Sorted by: Best Match Show Resources per page
It's Not All in the Conditioning or the Perils of Early Trial Cessation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Scott BL.
PMID: 30125667
Biol Blood Marrow Transplant. 2018 Oct;24(10):1957-1958. doi: 10.1016/j.bbmt.2018.08.014. Epub 2018 Aug 18.

No abstract available.

Cite
Scott BL. It's Not All in the Conditioning or the Perils of Early Trial Cessation. Biol Blood Marrow Transplant. 2018;24(10):1957-1958doi: 10.1016/j.bbmt.2018.08.014.
Scott, B. L. (2018). It's Not All in the Conditioning or the Perils of Early Trial Cessation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 24(10), 1957-1958. https://doi.org/10.1016/j.bbmt.2018.08.014
Scott, Bart L. "It's Not All in the Conditioning or the Perils of Early Trial Cessation." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation vol. 24,10 (2018): 1957-1958. doi: https://doi.org/10.1016/j.bbmt.2018.08.014
Scott BL. It's Not All in the Conditioning or the Perils of Early Trial Cessation. Biol Blood Marrow Transplant. 2018 Oct;24(10):1957-1958. doi: 10.1016/j.bbmt.2018.08.014. Epub 2018 Aug 18. PMID: 30125667.
Copy Download .nbib Format: NLM
Advising patients seeking stem cell interventions for multiple sclerosis.

Practical neurology

von Wunster B, Bailey S, Wilkins A, Marks DI, Scolding NJ, Rice CM.
PMID: 29848512
Pract Neurol. 2018 Dec;18(6):472-476. doi: 10.1136/practneurol-2018-001956. Epub 2018 May 30.

Given the intuitive potential of stem cell therapy and limitations of current treatment options for progressive multiple sclerosis (MS), it is not surprising that patients consider undertaking significant clinical and financial risks to access stem cell transplantation. However, while...

Cite
von Wunster B, Bailey S, Wilkins A, et al. Advising patients seeking stem cell interventions for multiple sclerosis. Pract Neurol. 2018;18(6):472-476doi: 10.1136/practneurol-2018-001956.
von Wunster, B., Bailey, S., Wilkins, A., Marks, D. I., Scolding, N. J., & Rice, C. M. (2018). Advising patients seeking stem cell interventions for multiple sclerosis. Practical neurology, 18(6), 472-476. https://doi.org/10.1136/practneurol-2018-001956
von Wunster, Beatrice, et al. "Advising patients seeking stem cell interventions for multiple sclerosis." Practical neurology vol. 18,6 (2018): 472-476. doi: https://doi.org/10.1136/practneurol-2018-001956
von Wunster B, Bailey S, Wilkins A, Marks DI, Scolding NJ, Rice CM. Advising patients seeking stem cell interventions for multiple sclerosis. Pract Neurol. 2018 Dec;18(6):472-476. doi: 10.1136/practneurol-2018-001956. Epub 2018 May 30. PMID: 29848512.
Copy Download .nbib Format: NLM
Pediatric Hematopoietic Stem Cell Transplantation in India: Status, Challenges and the Way Forward : Based on Dr. K. C. Chaudhuri Oration 2016.

Indian journal of pediatrics

Gupta VG, Bakhshi S.
PMID: 27832477
Indian J Pediatr. 2017 Jan;84(1):36-41. doi: 10.1007/s12098-016-2253-5. Epub 2016 Nov 10.

Hematopoietic stem cell transplantation (HSCT) refers to therapies that aim to eliminate a patient's hematopoietic and immune system and replace it with his own (autologous) or someone else's (allogenic) system. The applications of this therapy are vast and growing,...

Cite
Gupta VG, Bakhshi S. Pediatric Hematopoietic Stem Cell Transplantation in India: Status, Challenges and the Way Forward : Based on Dr. K. C. Chaudhuri Oration 2016. Indian J Pediatr. 2016;84(1):36-41doi: 10.1007/s12098-016-2253-5.
Gupta, V. G., & Bakhshi, S. (2017). Pediatric Hematopoietic Stem Cell Transplantation in India: Status, Challenges and the Way Forward : Based on Dr. K. C. Chaudhuri Oration 2016. Indian journal of pediatrics, 84(1), 36-41. https://doi.org/10.1007/s12098-016-2253-5
Gupta, Vineet Govinda, and Bakhshi, Sameer. "Pediatric Hematopoietic Stem Cell Transplantation in India: Status, Challenges and the Way Forward : Based on Dr. K. C. Chaudhuri Oration 2016." Indian journal of pediatrics vol. 84,1 (2017): 36-41. doi: https://doi.org/10.1007/s12098-016-2253-5
Gupta VG, Bakhshi S. Pediatric Hematopoietic Stem Cell Transplantation in India: Status, Challenges and the Way Forward : Based on Dr. K. C. Chaudhuri Oration 2016. Indian J Pediatr. 2017 Jan;84(1):36-41. doi: 10.1007/s12098-016-2253-5. Epub 2016 Nov 10. PMID: 27832477.
Copy Download .nbib Format: NLM
iNKT cells and hematopoietic stem cell transplantation: Two-phase activation of iNKT cells may improve outcome.

Clinical immunology (Orlando, Fla.)

Fereidouni M, Derakhshani A, Exley MA.
PMID: 31128279
Clin Immunol. 2019 Oct;207:43-48. doi: 10.1016/j.clim.2019.05.011. Epub 2019 May 23.

Invariant natural killer T cells (iNKT) produce large amounts of different cytokines which can influence differentiation, polarization and activation of immune cells, particularly NK and T cells. iNKT have been shown to suppress GvHD and promote anti-tumor and anti-pathogen...

Cite
Fereidouni M, Derakhshani A, Exley MA. iNKT cells and hematopoietic stem cell transplantation: Two-phase activation of iNKT cells may improve outcome. Clin Immunol. 2019;207:43-48doi: 10.1016/j.clim.2019.05.011.
Fereidouni, M., Derakhshani, A., & Exley, M. A. (2019). iNKT cells and hematopoietic stem cell transplantation: Two-phase activation of iNKT cells may improve outcome. Clinical immunology (Orlando, Fla.), 20743-48. https://doi.org/10.1016/j.clim.2019.05.011
Fereidouni, Mohammad, et al. "iNKT cells and hematopoietic stem cell transplantation: Two-phase activation of iNKT cells may improve outcome." Clinical immunology (Orlando, Fla.) vol. 207 (2019): 43-48. doi: https://doi.org/10.1016/j.clim.2019.05.011
Fereidouni M, Derakhshani A, Exley MA. iNKT cells and hematopoietic stem cell transplantation: Two-phase activation of iNKT cells may improve outcome. Clin Immunol. 2019 Oct;207:43-48. doi: 10.1016/j.clim.2019.05.011. Epub 2019 May 23. PMID: 31128279.
Copy Download .nbib Format: NLM
[Current status of hematopoietic stem cell transplantation].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine

Kodera Y.
PMID: 9780671
Nihon Naika Gakkai Zasshi. 1998 Aug 10;87(8):1457-63.

No abstract available.

Cite
Kodera Y. [Current status of hematopoietic stem cell transplantation]. Nihon Naika Gakkai Zasshi. 1998;87(8):1457-63
Kodera, Y. (1998). [Current status of hematopoietic stem cell transplantation]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 87(8), 1457-63.
Kodera, Y. "[Current status of hematopoietic stem cell transplantation]." Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine vol. 87,8 (1998): 1457-63.
Kodera Y. [Current status of hematopoietic stem cell transplantation]. Nihon Naika Gakkai Zasshi. 1998 Aug 10;87(8):1457-63. Japanese. PMID: 9780671.
Copy Download .nbib Format: NLM
Management of pediatric transplant patients in the emergency department.

Pediatric emergency medicine practice

DiFabio B, Ruttan T.
PMID: 34542249
Pediatr Emerg Med Pract. 2021 Oct;18(10):1-20. Epub 2021 Oct 02.

Transplant patients are at risk for illnesses and complications days, months, or years after transplantation, and they can present complex challenges for emergency clinicians. This review discusses the general approach to the management of pediatric transplant patients in the...

Cite
DiFabio B, Ruttan T. Management of pediatric transplant patients in the emergency department. Pediatr Emerg Med Pract. 2021;18(10):1-20
DiFabio, B., & Ruttan, T. (2021). Management of pediatric transplant patients in the emergency department. Pediatric emergency medicine practice, 18(10), 1-20.
DiFabio, Brittany, and Ruttan, Timothy. "Management of pediatric transplant patients in the emergency department." Pediatric emergency medicine practice vol. 18,10 (2021): 1-20.
DiFabio B, Ruttan T. Management of pediatric transplant patients in the emergency department. Pediatr Emerg Med Pract. 2021 Oct;18(10):1-20. Epub 2021 Oct 02. PMID: 34542249.
Copy Download .nbib Format: NLM
Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantation.

Blood advances

Ren X, Huang Q, Qu Q, Cai X, Fu H, Mo X, Wang Y, Zheng Y, Jiang E, Ye Y, Luo Y, Chen S, Yang T, Zhang Y, Han W, Tang F, Mo W, Wang S, Li F, Liu D, Zhang X, Zhang Y, Feng S, Gao F, Yuan H, Wang D, Wan D, Chen H, Chen Y, Wang J, Chen Y, Wang Y, Xu K, Lang T, Wang X, Meng H, Li L, Wang Z, Fan Y, Chang Y, Xu L, Huang X, Zhang X.
PMID: 34448835
Blood Adv. 2021 Dec 14;5(23):4910-4921. doi: 10.1182/bloodadvances.2021004349.

Intracranial hemorrhage (ICH) is a rare but fatal central nervous system complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, factors that are predictive of early mortality in patients who develop ICH after undergoing allo-HSCT have not been systemically...

Cite
Ren X, Huang Q, Qu Q, et al. Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantation. Blood Adv. 2021;5(23):4910-4921doi: 10.1182/bloodadvances.2021004349.
Ren, X., Huang, Q., Qu, Q., Cai, X., Fu, H., Mo, X., Wang, Y., Zheng, Y., Jiang, E., Ye, Y., Luo, Y., Chen, S., Yang, T., Zhang, Y., Han, W., Tang, F., Mo, W., Wang, S., Li, F., Liu, D., Zhang, X., Zhang, Y., Feng, S., Gao, F., Yuan, H., Wang, D., Wan, D., Chen, H., Chen, Y., Wang, J., Chen, Y., Wang, Y., Xu, K., Lang, T., Wang, X., Meng, H., Li, L., Wang, Z., Fan, Y., Chang, Y., Xu, L., Huang, X., & Zhang, X. (2021). Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantation. Blood advances, 5(23), 4910-4921. https://doi.org/10.1182/bloodadvances.2021004349
Ren, Xiying, et al. "Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantation." Blood advances vol. 5,23 (2021): 4910-4921. doi: https://doi.org/10.1182/bloodadvances.2021004349
Ren X, Huang Q, Qu Q, Cai X, Fu H, Mo X, Wang Y, Zheng Y, Jiang E, Ye Y, Luo Y, Chen S, Yang T, Zhang Y, Han W, Tang F, Mo W, Wang S, Li F, Liu D, Zhang X, Zhang Y, Feng S, Gao F, Yuan H, Wang D, Wan D, Chen H, Chen Y, Wang J, Chen Y, Wang Y, Xu K, Lang T, Wang X, Meng H, Li L, Wang Z, Fan Y, Chang Y, Xu L, Huang X, Zhang X. Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantation. Blood Adv. 2021 Dec 14;5(23):4910-4921. doi: 10.1182/bloodadvances.2021004349. PMID: 34448835.
Copy Download .nbib Format: NLM
EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity.

Bone marrow transplantation

Lankester AC, Albert MH, Booth C, Gennery AR, Güngör T, Hönig M, Morris EC, Moshous D, Neven B, Schulz A, Slatter M, Veys P.
PMID: 34226669
Bone Marrow Transplant. 2021 Sep;56(9):2052-2062. doi: 10.1038/s41409-021-01378-8. Epub 2021 Jul 05.

No abstract available.

Cite
Lankester AC, Albert MH, Booth C, et al. EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity. Bone Marrow Transplant. 2021;56(9):2052-2062doi: 10.1038/s41409-021-01378-8.
Lankester, A. C., Albert, M. H., Booth, C., Gennery, A. R., Güngör, T., Hönig, M., Morris, E. C., Moshous, D., Neven, B., Schulz, A., Slatter, M., Veys, P. (2021). EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity. Bone marrow transplantation, 56(9), 2052-2062. https://doi.org/10.1038/s41409-021-01378-8
Lankester, A C, et al. "EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity." Bone marrow transplantation vol. 56,9 (2021): 2052-2062. doi: https://doi.org/10.1038/s41409-021-01378-8
Lankester AC, Albert MH, Booth C, Gennery AR, Güngör T, Hönig M, Morris EC, Moshous D, Neven B, Schulz A, Slatter M, Veys P. EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity. Bone Marrow Transplant. 2021 Sep;56(9):2052-2062. doi: 10.1038/s41409-021-01378-8. Epub 2021 Jul 05. PMID: 34226669; PMCID: PMC8410590.
Copy Download .nbib Format: NLM
A prognostic model (BATAP) with external validation for patients with transplant-associated thrombotic microangiopathy.

Blood advances

Zhao P, Wu YJ, He Y, Chong S, Qu QY, Deng RX, Sun XW, Huang QS, Liu X, Zhu XL, Wang FR, Zhang YY, Mo XD, Han W, Wang JZ, Wang Y, Chen H, Chen YH, Zhao XY, Chang YJ, Xu LP, Liu KY, Huang XJ, Zhang XH.
PMID: 34507352
Blood Adv. 2021 Dec 28;5(24):5479-5489. doi: 10.1182/bloodadvances.2021004530.

Transplant-associated thrombotic microangiopathy (TA-TMA) is a potentially life-threatening complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Information on markers for early prognostication remains limited, and no predictive tools for TA-TMA are available. We attempted to develop and validate a...

Cite
Zhao P, Wu YJ, He Y, et al. A prognostic model (BATAP) with external validation for patients with transplant-associated thrombotic microangiopathy. Blood Adv. 2021;5(24):5479-5489doi: 10.1182/bloodadvances.2021004530.
Zhao, P., Wu, Y. J., He, Y., Chong, S., Qu, Q. Y., Deng, R. X., Sun, X. W., Huang, Q. S., Liu, X., Zhu, X. L., Wang, F. R., Zhang, Y. Y., Mo, X. D., Han, W., Wang, J. Z., Wang, Y., Chen, H., Chen, Y. H., Zhao, X. Y., Chang, Y. J., Xu, L. P., Liu, K. Y., Huang, X. J., & Zhang, X. H. (2021). A prognostic model (BATAP) with external validation for patients with transplant-associated thrombotic microangiopathy. Blood advances, 5(24), 5479-5489. https://doi.org/10.1182/bloodadvances.2021004530
Zhao, Peng, et al. "A prognostic model (BATAP) with external validation for patients with transplant-associated thrombotic microangiopathy." Blood advances vol. 5,24 (2021): 5479-5489. doi: https://doi.org/10.1182/bloodadvances.2021004530
Zhao P, Wu YJ, He Y, Chong S, Qu QY, Deng RX, Sun XW, Huang QS, Liu X, Zhu XL, Wang FR, Zhang YY, Mo XD, Han W, Wang JZ, Wang Y, Chen H, Chen YH, Zhao XY, Chang YJ, Xu LP, Liu KY, Huang XJ, Zhang XH. A prognostic model (BATAP) with external validation for patients with transplant-associated thrombotic microangiopathy. Blood Adv. 2021 Dec 28;5(24):5479-5489. doi: 10.1182/bloodadvances.2021004530. PMID: 34507352; PMCID: PMC8714708.
Copy Download .nbib Format: NLM
COVID-19 pandemic: educational technology for post-hematopoietic stem cell transplant patients.

Revista brasileira de enfermagem

Piubello SMN, Reichembach MT, Pontes L, Boller S.
PMID: 34161518
Rev Bras Enferm. 2021 Jun 16;74:e20201088. doi: 10.1590/0034-7167-2020-1088. eCollection 2021.

OBJECTIVE: to describe the experience of building the technology "Care for the prevention of COVID-19 in post-hematopoietic stem cell transplant patients".METHODS: experience report conducted in a hematopoietic stem cell transplant outpatient clinic that supported the construction of an educational...

Cite
Piubello SMN, Reichembach MT, Pontes L, et al. COVID-19 pandemic: educational technology for post-hematopoietic stem cell transplant patients. Rev Bras Enferm. 2021;74:e20201088doi: 10.1590/0034-7167-2020-1088.
Piubello, S. M. N., Reichembach, M. T., Pontes, L., & Boller, S. (2021). COVID-19 pandemic: educational technology for post-hematopoietic stem cell transplant patients. Revista brasileira de enfermagem, 74e20201088. https://doi.org/10.1590/0034-7167-2020-1088
Piubello, Simone Martins Nascimento, et al. "COVID-19 pandemic: educational technology for post-hematopoietic stem cell transplant patients." Revista brasileira de enfermagem vol. 74 (2021): e20201088. doi: https://doi.org/10.1590/0034-7167-2020-1088
Piubello SMN, Reichembach MT, Pontes L, Boller S. COVID-19 pandemic: educational technology for post-hematopoietic stem cell transplant patients. Rev Bras Enferm. 2021 Jun 16;74:e20201088. doi: 10.1590/0034-7167-2020-1088. eCollection 2021. Portuguese. PMID: 34161518.
Copy Download .nbib Format: NLM
Thoughts from the threshold: patient and family hopes, fears, values, and goals at the onset of pediatric hematopoietic cell transplantation.

Bone marrow transplantation

Levine DR, Van Noy K, Talleur AC, Snyder A, Kaye EC, Baker JN.
PMID: 31992844
Bone Marrow Transplant. 2020 Jun;55(6):1103-1113. doi: 10.1038/s41409-020-0794-8. Epub 2020 Jan 28.

Hematopoietic cell transplantation (HCT) affords curative potential for high-risk patients but also carries risk of morbidity and mortality. Early palliative care (PC) integration can aid in supporting patients and families, fostering goal-directed care, and maximizing quality-of-life throughout. However, little...

Cite
Levine DR, Van Noy K, Talleur AC, et al. Thoughts from the threshold: patient and family hopes, fears, values, and goals at the onset of pediatric hematopoietic cell transplantation. Bone Marrow Transplant. 2020;55(6):1103-1113doi: 10.1038/s41409-020-0794-8.
Levine, D. R., Van Noy, K., Talleur, A. C., Snyder, A., Kaye, E. C., & Baker, J. N. (2020). Thoughts from the threshold: patient and family hopes, fears, values, and goals at the onset of pediatric hematopoietic cell transplantation. Bone marrow transplantation, 55(6), 1103-1113. https://doi.org/10.1038/s41409-020-0794-8
Levine, Deena R, et al. "Thoughts from the threshold: patient and family hopes, fears, values, and goals at the onset of pediatric hematopoietic cell transplantation." Bone marrow transplantation vol. 55,6 (2020): 1103-1113. doi: https://doi.org/10.1038/s41409-020-0794-8
Levine DR, Van Noy K, Talleur AC, Snyder A, Kaye EC, Baker JN. Thoughts from the threshold: patient and family hopes, fears, values, and goals at the onset of pediatric hematopoietic cell transplantation. Bone Marrow Transplant. 2020 Jun;55(6):1103-1113. doi: 10.1038/s41409-020-0794-8. Epub 2020 Jan 28. PMID: 31992844; PMCID: PMC8722457.
Copy Download .nbib Format: NLM
The role of mesenchymal stem cells in hematopoietic stem cell transplantation: from bench to bedsides.

Cell transplantation

Wu KH, Wu HP, Chan CK, Hwang SM, Peng CT, Chao YH.
PMID: 23068433
Cell Transplant. 2013;22(4):723-9. doi: 10.3727/096368912X655217. Epub 2012 Oct 12.

Mesenchymal stem cells (MSCs) have been shown to be effective in the management of graft-versus-host disease (GVHD) due to their immunomodulatory effects. In addition to prevention and treatment of GVHD, many studies have demonstrated that MSCs can promote hematopoietic...

Cite
Wu KH, Wu HP, Chan CK, et al. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: from bench to bedsides. Cell Transplant. 2012;22(4):723-9doi: 10.3727/096368912X655217.
Wu, K. H., Wu, H. P., Chan, C. K., Hwang, S. M., Peng, C. T., & Chao, Y. H. (2013). The role of mesenchymal stem cells in hematopoietic stem cell transplantation: from bench to bedsides. Cell transplantation, 22(4), 723-9. https://doi.org/10.3727/096368912X655217
Wu, Kang-Hsi, et al. "The role of mesenchymal stem cells in hematopoietic stem cell transplantation: from bench to bedsides." Cell transplantation vol. 22,4 (2013): 723-9. doi: https://doi.org/10.3727/096368912X655217
Wu KH, Wu HP, Chan CK, Hwang SM, Peng CT, Chao YH. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: from bench to bedsides. Cell Transplant. 2013;22(4):723-9. doi: 10.3727/096368912X655217. Epub 2012 Oct 12. PMID: 23068433.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 26 entries